FUNDING

Heru Completes FDA Registration Following a $2.7M Seed Round: Expands Leadership Team

The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts.

Peptilogics Closes $35.4 Million Series B Financing

The proceeds of the financing will be used to expand Peptilogics' computational platform and invest in technologies to improve its drug design engine, as well as accelerate the development of a pipeline of peptide therapeutics

Ingenion Medical Wins Innovate £100,000 UK Grant – Funds to Be Used to Gain a CE Mark for Its CymActive™ Urinary Catheter

December 18, 2020 Ingenion Medical today, announces it has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency. Ingenion Medical will use...

Rhia Ventures Invests in OCON Healthcare’s Ballerine – the 1st & Only 3D Sperical Copper IUB

Rhia Ventures notes the financing will also help expand Phase II clinical trials for OCON's SEADTM product, which offers point-of-care therapy for abnormal uterine bleeding.

Verily Announces $700 Million Investment Round from Current Investors: Funds to Support Rapid Commercial Expansion

Verily current investors, include Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.

Pacific6 Enterprises and JM Molina Investments Announce a Joint Investment in Detact Diagnostics

Pacific6 is an investment partnership founded, in part, by John Molina, the former CFO of Molina Healthcare. His brother, J. Mario Molina, M.D., former CEO of Molina Healthcare, is the principal behind JM Molina Investments.

Senecio Robotics Awarded $12 Million

With nearly 700 million people infected with a mosquito-borne disease every year, as well as the increase in mosquito populations driven by a warming climate, it is a massive and growing challenge to fight them using only traditional approaches.

osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR

The funds raised will be used to promote the further geographical expansion of osteolabs GmbH in the Scandinavian countries, the BENELUX countries, Switzerland and Austria.

Basking Biosciences Completes $5.4M Seed Financing: Funds to Support Development of the 1st Reversible Thrombolytic Therapy for Acute Ischemic Stroke

The investor syndicate includes Rev1 Ventures, Broadview Ventures, and Viva BioInnovator. Concurrent with the financing, Ryan Helon of Rev1, Thomas Needham of Broadview, and Dr. Dan Meyers have joined Basking’s Board of Directors.
Medical Device News Magazinespot_img